Dr. Reddy's Laboratories

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RDY and other ETFs, options, and stocks.

About RDY

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. 

CEO
Erez Israeli
CEOErez Israeli
Employees
27,811
Employees27,811
Headquarters
Hyderabad, Telangana
HeadquartersHyderabad, Telangana
Founded
1984
Founded1984
Employees
27,811
Employees27,811

RDY Key Statistics

Market cap
11.89B
Market cap11.89B
Price-Earnings ratio
18.32
Price-Earnings ratio18.32
Dividend yield
0.50%
Dividend yield0.50%
Average volume
1.83M
Average volume1.83M
High today
$14.32
High today$14.32
Low today
$14.16
Low today$14.16
Open price
$14.27
Open price$14.27
Volume
1.97M
Volume1.97M
52 Week high
$16.17
52 Week high$16.17
52 Week low
$12.26
52 Week low$12.26

RDY News

TipRanks 18h
Dr. Reddy’s Srikakulam Plant Clears USFDA Inspection With VAI Classification

Dr. Reddy’s Laboratories Ltd. ( (IN:DRREDDY) ) has provided an update. Dr. Reddy’s Laboratories has received the Establishment Inspection Report from the U.S....

TipRanks 7d
Dr. Reddy’s Schedules Analyst and Investor Meets for Early March 2026

Dr Reddy’s Laboratories ( (RDY) ) just unveiled an announcement. Dr. Reddy’s Laboratories has notified stock exchanges that its management will meet analysts a...

Analyst ratings

36%

of 36 ratings
Buy
36.1%
Hold
33.3%
Sell
30.6%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.